Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

KTTA

$0.54-5.21%

Pasithea Therapeutics Corp.

Market Cap
$19M
Sector
Materials
Industry
Biotechnology
Beta
0.31
5yr monthly vs SPY
Price Chart
Loading…

Signals

Insider Velocity
24.0x
buying
Congress
—
recent trades
Short Volume
38%
W/W -9.7pp

Market & Alt Data

News
10
recent articles
Activist
13D
Pasithea
Analyst Consensus
Strong Buy
7 analysts
Velocity Score
23.98x
Current Rate (90d)
1111.11/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
1
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-06-172026-06-22Coastlands Capital LP10% OwnerPurchase100.0K$0.53$53K3.84MView

Recent News

Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
Yahoo · 2026-09-03
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 2026-08-21
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Yahoo Finance · 2026-07-08
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
Yahoo Finance · 2026-06-15

Informational purposes only, not investment advice.

Pasithea Therapeutics (KTTA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Yahoo Finance · 2026-06-10
Pasithea Therapeutics Announces Orphan Drug Designation by FDA of PAS-004 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
Yahoo Finance · 2026-06-02
Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer
Yahoo Finance · 2026-05-04
Is Pasithea Therapeutics (NASDAQ:KTTA) In A Good Position To Deliver On Growth Plans?
Yahoo Finance · 2026-05-03
Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)
Yahoo Finance · 2026-04-20
Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity
Yahoo Finance · 2026-04-01

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →